Loading...
Header Logo
Keywords
Last Name
Institution

Jie Wu

TitleProf
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentStephenson Cancer Center
Address800 NE 10th St
Oklahoma City OK 73104-0001
Phone405/271-8001
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Kansas Medical Center, Kansas City, MOPhD1988Biochemistry
    Memorial Sloan-Kettering Cancer Center, New York, NYFellow1990Molecular Biology
    University of Virginia, Charlettsville, VAPostdoc1994Medicine and Pharmacology

    Collapse Research 
    Collapse research activities and funding
    R01CA178456     (WU, JIE)Jul 8, 2013 - Apr 30, 2018
    NIH/NCI
    Roles of PTPN11 in regulating and driving epithelial cancer
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wu J, Li Z, Li Y, Pettitt A, Zhou F. Photothermal Effects of Reduced Graphene Oxide on Pancreatic Cancer. Technol Cancer Res Treat. 2018 Jan 01; 17:1533034618768637. PMID: 29665743.
      View in: PubMed
    2. Cress WD, Yu P, Wu J. Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer. Int J Biochem Cell Biol. 2017 10; 91(Pt B):98-101. PMID: 28504190.
      View in: PubMed
    3. Shen T, Chen Z, Zhao ZJ, Wu J. Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the JAK2 gene in non-small cell lung cancer. Oncotarget. 2017 Sep 22; 8(37):60975-60986. PMID: 28977839.
      View in: PubMed
    4. Huang Q, Schneeberger VE, Luetteke N, Jin C, Afzal R, Budzevich MM, Makanji RJ, Martinez GV, Shen T, Zhao L, Fung KM, Haura EB, Coppola D, Wu J. Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma. Mol Cancer Ther. 2016 10; 15(10):2521-2529. PMID: 27496134.
      View in: PubMed
    5. Fan C, Chen L, Huang Q, Shen T, Welsh EA, Teer JK, Cai J, Cress WD, Wu J. Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma. Br J Cancer. 2015 Dec 22; 113(12):1735-43. PMID: 26554648; PMCID: PMC4701993 [Available on 12/22/16].
    6. Schneeberger VE, Ren Y, Luetteke N, Huang Q, Chen L, Lawrence HR, Lawrence NJ, Haura EB, Koomen JM, Coppola D, Wu J. Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma. Oncotarget. 2015 Mar 20; 6(8):6191-202. PMID: 25730908; PMCID: PMC4467431.
    7. Fang B, Hoffman MA, Mirza AS, Mishall KM, Li J, Peterman SM, Smalley KS, Shain KH, Weinberger PM, Wu J, Rix U, Haura EB, Koomen JM. Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides. Methods. 2015 Jun 15; 81:41-9. PMID: 25782629; PMCID: PMC4460980.
    8. Schneeberger VE, Luetteke N, Ren Y, Berns H, Chen L, Foroutan P, Martinez GV, Haura EB, Chen J, Coppola D, Wu J. SHP2E76K mutant promotes lung tumorigenesis in transgenic mice. Carcinogenesis. 2014 Aug; 35(8):1717-25. PMID: 24480804; PMCID: PMC4123642.
    9. Ren Y, Zhang Y, Liu RZ, Fenstermacher DA, Wright KL, Teer JK, Wu J. JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations. Sci Rep. 2013 Oct 24; 3:3042. PMID: 24154688; PMCID: PMC3807107.
    10. Sui H, Liu X, Jin BH, Pan SF, Zhou LH, Yu NA, Wu J, Cai JF, Fan ZZ, Zhu HR, Li Q. Zuo Jin Wan, a Traditional Chinese Herbal Formula, Reverses P-gp-Mediated MDR In Vitro and In Vivo. Evid Based Complement Alternat Med. 2013; 2013:957078. PMID: 23533531; PMCID: PMC3603672.
    11. Zhu X, Li Z, Pan W, Qin L, Zhu G, Ke Y, Wu J, Bo P, Meng S. Participation of Gab1 and Gab2 in IL-22-mediated keratinocyte proliferation, migration, and differentiation. Mol Cell Biochem. 2012 Oct; 369(1-2):255-66. PMID: 22851227.
      View in: PubMed
    12. Win-Piazza H, Schneeberger VE, Chen L, Pernazza D, Lawrence HR, Sebti SM, Lawrence NJ, Wu J. Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2. Cancer Lett. 2012 Jul 01; 320(1):81-5. PMID: 22306001; PMCID: PMC3319810.
    13. Pagán B, Isidro AA, Cruz ML, Ren Y, Coppola D, Wu J, Appleyard CB. Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model. World J Gastroenterol. 2011 Nov 28; 17(44):4858-66. PMID: 22171126; PMCID: PMC3235628.
    14. Shen Z, Zhang X, Tang J, Kasiappan R, Jinwal U, Li P, Hann S, Nicosia SV, Wu J, Zhang X, Bai W. The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells. Mol Cell Endocrinol. 2011 May 16; 338(1-2):58-67. PMID: 21458521; PMCID: PMC3089697.
    15. Fragale A, Stellacci E, Ilari R, Remoli AL, Lanciotti A, Perrotti E, Shytaj I, Orsatti R, Lawrence HR, Lawrence NJ, Wu J, Rehli M, Ozato K, Battistini A. Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing protein tyrosine phosphatase-2 activity in human myeloid dendritic cells. J Immunol. 2011 Feb 15; 186(4):1951-62. PMID: 21220691; PMCID: PMC4053178.
    16. Scott LM, Chen L, Daniel KG, Brooks WH, Guida WC, Lawrence HR, Sebti SM, Lawrence NJ, Wu J. Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs. Bioorg Med Chem Lett. 2011 Jan 15; 21(2):730-3. PMID: 21193311; PMCID: PMC3034307.
    17. Philpott N, Bakken T, Pennell C, Chen L, Wu J, Cannon M. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor contains an immunoreceptor tyrosine-based inhibitory motif that activates Shp2. J Virol. 2011 Jan; 85(2):1140-4. PMID: 21047965; PMCID: PMC3020031.
    18. Ren Y, Chen Z, Chen L, Fang B, Win-Piazza H, Haura E, Koomen JM, Wu J. Critical role of Shp2 in tumor growth involving regulation of c-Myc. Genes Cancer. 2010 Oct; 1(10):994-1007. PMID: 21442024.
      View in: PubMed
    19. Pagán B, Isidro AA, Coppola D, Chen Z, Ren Y, Wu J, Appleyard CB. Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer. Anticancer Res. 2010 Sep; 30(9):3345-53. PMID: 20944107; PMCID: PMC3733557.
    20. Meng S, Gui Q, Xu Q, Lu K, Jiao X, Fan J, Ge B, Ke Y, Zhang S, Wu J, Wang C. Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation. J Mol Cell Biol. 2010 Aug; 2(4):223-30. PMID: 20671117; PMCID: PMC2948820.
    21. Chen L, Pernazza D, Scott LM, Lawrence HR, Ren Y, Luo Y, Wu X, Sung SS, Guida WC, Sebti SM, Lawrence NJ, Wu J. Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112. Biochem Pharmacol. 2010 Sep 15; 80(6):801-10. PMID: 20510203; PMCID: PMC2906681.
    22. Lawrence HR, Pireddu R, Chen L, Luo Y, Sung SS, Szymanski AM, Yip ML, Guida WC, Sebti SM, Wu J, Lawrence NJ. Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds. J Med Chem. 2008 Aug 28; 51(16):4948-56. PMID: 18680359; PMCID: PMC2744494.
    23. Yamaguchi H, Woods NT, Dorsey JF, Takahashi Y, Gjertsen NR, Yeatman T, Wu J, Wang HG. SRC directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis. J Biol Chem. 2008 Jul 04; 283(27):19112-8. PMID: 18474606; PMCID: PMC2441553.
    24. Wahle JA, Paraiso KH, Kendig RD, Lawrence HR, Chen L, Wu J, Kerr WG. Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell. J Immunol. 2007 Dec 15; 179(12):8009-15. PMID: 18056340.
      View in: PubMed
    25. Ren Y, Chen Z, Chen L, Woods NT, Reuther GW, Cheng JQ, Wang HG, Wu J. Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL. J Biol Chem. 2007 Dec 14; 282(50):36463-73. PMID: 17942397; PMCID: PMC3000740.
    26. Fiskus W, Ren Y, Mohapatra A, Bali P, Mandawat A, Rao R, Herger B, Yang Y, Atadja P, Wu J, Bhalla K. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90. Clin Cancer Res. 2007 Aug 15; 13(16):4882-90. PMID: 17699868.
      View in: PubMed
    27. Chen L, Sung SS, Yip ML, Lawrence HR, Ren Y, Guida WC, Sebti SM, Lawrence NJ, Wu J. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol Pharmacol. 2006 Aug; 70(2):562-70. PMID: 16717135.
      View in: PubMed
    28. Fiskus W, Pranpat M, Bali P, Balasis M, Kumaraswamy S, Boyapalle S, Rocha K, Wu J, Giles F, Manley PW, Atadja P, Bhalla K. Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells. Blood. 2006 Jul 15; 108(2):645-52. PMID: 16537804.
      View in: PubMed
    29. Chen Z, Lee FY, Bhalla KN, Wu J. Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib). Mol Pharmacol. 2006 May; 69(5):1527-33. PMID: 16436588.
      View in: PubMed
    30. Takahashi Y, Karbowski M, Yamaguchi H, Kazi A, Wu J, Sebti SM, Youle RJ, Wang HG. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol. 2005 Nov; 25(21):9369-82. PMID: 16227588; PMCID: PMC1265816.
    31. Meng S, Chen Z, Munoz-Antonia T, Wu J. Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor. Biochem J. 2005 Oct 01; 391(Pt 1):143-51. PMID: 15952937; PMCID: PMC1237148.
    32. Chen L, Meng S, Wang H, Bali P, Bai W, Li B, Atadja P, Bhalla KN, Wu J. Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824. Mol Cancer Ther. 2005 Sep; 4(9):1311-9. PMID: 16170022.
      View in: PubMed
    33. Jin ZG, Wong C, Wu J, Berk BC. Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells. J Biol Chem. 2005 Apr 01; 280(13):12305-9. PMID: 15665327; PMCID: PMC4228934.
    34. Guo F, Sigua C, Bali P, George P, Fiskus W, Scuto A, Annavarapu S, Mouttaki A, Sondarva G, Wei S, Wu J, Djeu J, Bhalla K. Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells. Blood. 2005 Feb 01; 105(3):1246-55. PMID: 15388581.
      View in: PubMed
    35. Fragale A, Tartaglia M, Wu J, Gelb BD. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum Mutat. 2004 Mar; 23(3):267-77. PMID: 14974085.
      View in: PubMed
    36. Kong X, San Juan H, Behera A, Peeples ME, Wu J, Lockey RF, Mohapatra SS. ERK-1/2 activity is required for efficient RSV infection. FEBS Lett. 2004 Feb 13; 559(1-3):33-8. PMID: 14960303.
      View in: PubMed
    37. Sun Y, Yuan J, Liu H, Shi Z, Baker K, Vuori K, Wu J, Feng GS. Role of Gab1 in UV-induced c-Jun NH2-terminal kinase activation and cell apoptosis. Mol Cell Biol. 2004 Feb; 24(4):1531-9. PMID: 14749370; PMCID: PMC344197.
    38. Ren Y, Meng S, Mei L, Zhao ZJ, Jove R, Wu J. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J Biol Chem. 2004 Feb 27; 279(9):8497-505. PMID: 14665621.
      View in: PubMed
    39. Nimmanapalli R, Bali P, O'Bryan E, Fuino L, Guo F, Wu J, Houghton P, Bhalla K. Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells. Cancer Res. 2003 Nov 15; 63(22):7950-8. PMID: 14633726.
      View in: PubMed
    40. Nimmanapalli R, Fuino L, Bali P, Gasparetto M, Glozak M, Tao J, Moscinski L, Smith C, Wu J, Jove R, Atadja P, Bhalla K. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. Cancer Res. 2003 Aug 15; 63(16):5126-35. PMID: 12941844.
      View in: PubMed
    41. Ren Y, Wu J. Simultaneous suppression of Erk and Akt/PKB activation by a Gab1 pleckstrin homology (PH) domain decoy. Anticancer Res. 2003 Jul-Aug; 23(4):3231-6. PMID: 12926057.
      View in: PubMed
    42. Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Mora LB, Niu G, Sinibaldi D, Bai F, Kraker A, Yu H, Moscinski L, Wei S, Djeu J, Dalton WS, Bhalla K, Loughran TP, Wu J, Jove R. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene. 2002 Dec 12; 21(57):8804-16. PMID: 12483533.
      View in: PubMed
    43. Kim SO, Loesch K, Wang X, Jiang J, Mei L, Cunnick JM, Wu J, Frank SJ. A role for Grb2-associated binder-1 in growth hormone signaling. Endocrinology. 2002 Dec; 143(12):4856-67. PMID: 12446613.
      View in: PubMed
    44. Dorsey JF, Cunnick JM, Lanehart R, Huang M, Kraker AJ, Bhalla KN, Jove R, Wu J. Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors. Leukemia. 2002 Sep; 16(9):1589-95. PMID: 12200668.
      View in: PubMed
    45. Yang J, Kim O, Wu J, Qiu Y. Interaction between tyrosine kinase Etk and a RUN domain- and FYVE domain-containing protein RUFY1. A possible role of ETK in regulation of vesicle trafficking. J Biol Chem. 2002 Aug 16; 277(33):30219-26. PMID: 11877430.
      View in: PubMed
    46. Dorsey JF, Cunnick JM, Mane SM, Wu J. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2. Blood. 2002 Feb 15; 99(4):1388-97. PMID: 11830491.
      View in: PubMed
    47. Cunnick JM, Meng S, Ren Y, Desponts C, Wang HG, Djeu JY, Wu J. Regulation of the mitogen-activated protein kinase signaling pathway by SHP2. J Biol Chem. 2002 Mar 15; 277(11):9498-504. PMID: 11779868.
      View in: PubMed
    48. Cunnick JM, Mei L, Doupnik CA, Wu J. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2. J Biol Chem. 2001 Jun 29; 276(26):24380-7. PMID: 11323411.
      View in: PubMed
    49. Dorsey JF, Jove R, Kraker AJ, Wu J. The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells. Cancer Res. 2000 Jun 15; 60(12):3127-31. PMID: 10866298.
      View in: PubMed
    50. Cunnick JM, Dorsey JF, Munoz-Antonia T, Mei L, Wu J. Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor. J Biol Chem. 2000 May 05; 275(18):13842-8. PMID: 10788507.
      View in: PubMed
    51. Sekharam M, Cunnick JM, Wu J. Involvement of lipoxygenase in lysophosphatidic acid-stimulated hydrogen peroxide release in human HaCaT keratinocytes. Biochem J. 2000 Mar 15; 346 Pt 3:751-8. PMID: 10698703; PMCID: PMC1220909.
    52. Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol. 1999 Nov; 19(11):7519-28. PMID: 10523640; PMCID: PMC84756.
    53. Yu R, Lei W, Mandlekar S, Weber MJ, Der CJ, Wu J, Kong AN. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J Biol Chem. 1999 Sep 24; 274(39):27545-52. PMID: 10488090.
      View in: PubMed
    54. Hu X, Moscinski LC, Hill BJ, Chen Q, Wu J, Fisher AB, Zuckerman KS. Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed event. Leuk Res. 1998 Sep; 22(9):817-26. PMID: 9716013.
      View in: PubMed
    55. Cunnick JM, Dorsey JF, Mei L, Wu J. Reversible regulation of SHP-1 tyrosine phosphatase activity by oxidation. Biochem Mol Biol Int. 1998 Aug; 45(5):887-94. PMID: 9739453.
      View in: PubMed
    56. Cunnick JM, Dorsey JF, Standley T, Turkson J, Kraker AJ, Fry DW, Jove R, Wu J. Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. J Biol Chem. 1998 Jun 05; 273(23):14468-75. PMID: 9603960.
      View in: PubMed
    57. Liu RY, Fan C, Mitchell S, Chen Q, Wu J, Zuckerman KS. The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNF-alpha to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e. Cancer Res. 1998 May 15; 58(10):2217-23. PMID: 9605769.
      View in: PubMed
    58. Sekharam M, Trotti A, Cunnick JM, Wu J. Suppression of fibroblast cell cycle progression in G1 phase by N-acetylcysteine. Toxicol Appl Pharmacol. 1998 Apr; 149(2):210-6. PMID: 9571990.
      View in: PubMed
    59. Rani CS, Wang F, Fuior E, Berger A, Wu J, Sturgill TW, Beitner-Johnson D, LeRoith D, Varticovski L, Spiegel S. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling. J Biol Chem. 1997 Apr 18; 272(16):10777-83. PMID: 9099730.
      View in: PubMed
    60. Stofega MR, Yu CL, Wu J, Jove R. Activation of extracellular signal-regulated kinase (ERK) by mitogenic stimuli is repressed in v-Src-transformed cells. Cell Growth Differ. 1997 Jan; 8(1):113-9. PMID: 8993840.
      View in: PubMed
    61. Chen Q, Olashaw N, Wu J. Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem. 1995 Dec 01; 270(48):28499-502. PMID: 7499358.
      View in: PubMed
    62. Wu J, Spiegel S, Sturgill TW. Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism. J Biol Chem. 1995 May 12; 270(19):11484-8. PMID: 7744787.
      View in: PubMed
    63. Wu J, Lau LF, Sturgill TW. Rapid deactivation of MAP kinase in PC12 cells occurs independently of induction of phosphatase MKP-1. FEBS Lett. 1994 Oct 10; 353(1):9-12. PMID: 7926031.
      View in: PubMed
    64. Yu SM. Thaliporphine selectively inhibits expression of the inducible, but not the constitutive, nitric oxide synthase. Biochem J. 1994 Oct 01; 303 ( Pt 1):289-94. PMID: 7524482; PMCID: PMC1137589.
    65. Aziz N, Wu J, Dubendorff JW, Lipsick JS, Sturgill TW, Bender TP. c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro. Oncogene. 1993 Aug; 8(8):2259-65. PMID: 8336948.
      View in: PubMed
    66. Wu J, Harrison JK, Dent P, Lynch KR, Weber MJ, Sturgill TW. Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2. Mol Cell Biol. 1993 Aug; 13(8):4539-48. PMID: 8393135; PMCID: PMC360070.
    67. Haystead CM, Wu J, Gregory P, Sturgill TW, Haystead TA. Functional expression of a MAP kinase kinase in COS cells and recognition by an anti-STE7/byr1 antibody. FEBS Lett. 1993 Feb 08; 317(1-2):12-6. PMID: 8428620.
      View in: PubMed
    68. Wu J, Harrison JK, Vincent LA, Haystead C, Haystead TA, Michel H, Hunt DF, Lynch KR, Sturgill TW. Molecular structure of a protein-tyrosine/threonine kinase activating p42 mitogen-activated protein (MAP) kinase: MAP kinase kinase. Proc Natl Acad Sci U S A. 1993 Jan 01; 90(1):173-7. PMID: 8380494; PMCID: PMC45622.
    69. Wu J, Michel H, Rossomando A, Haystead T, Shabanowitz J, Hunt DF, Sturgill TW. Renaturation and partial peptide sequencing of mitogen-activated protein kinase (MAP kinase) activator from rabbit skeletal muscle. Biochem J. 1992 Aug 01; 285 ( Pt 3):701-5. PMID: 1379797; PMCID: PMC1132850.
    70. Haystead TA, Dent P, Wu J, Haystead CM, Sturgill TW. Ordered phosphorylation of p42mapk by MAP kinase kinase. FEBS Lett. 1992 Jul 13; 306(1):17-22. PMID: 1628739.
      View in: PubMed
    71. Rossomando A, Wu J, Weber MJ, Sturgill TW. The phorbol ester-dependent activator of the mitogen-activated protein kinase p42mapk is a kinase with specificity for the threonine and tyrosine regulatory sites. Proc Natl Acad Sci U S A. 1992 Jun 15; 89(12):5221-5. PMID: 1319055; PMCID: PMC49263.
    72. Nakielny S, Cohen P, Wu J, Sturgill T. MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J. 1992 Jun; 11(6):2123-9. PMID: 1318193; PMCID: PMC556679.
    73. L'Allemain G, Her JH, Wu J, Sturgill TW, Weber MJ. Growth factor-induced activation of a kinase activity which causes regulatory phosphorylation of p42/microtubule-associated protein kinase. Mol Cell Biol. 1992 May; 12(5):2222-9. PMID: 1314951; PMCID: PMC364394.
    74. Wu J, Rossomando AJ, Her JH, Del Vecchio R, Weber MJ, Sturgill TW. Autophosphorylation in vitro of recombinant 42-kilodalton mitogen-activated protein kinase on tyrosine. Proc Natl Acad Sci U S A. 1991 Nov 01; 88(21):9508-12. PMID: 1835084; PMCID: PMC52747.
    75. Her JH, Wu J, Rall TB, Sturgill TW, Weber MJ. Sequence of pp42/MAP kinase, a serine/threonine kinase regulated by tyrosine phosphorylation. Nucleic Acids Res. 1991 Jul 11; 19(13):3743. PMID: 1649458; PMCID: PMC328408.
    76. Goldsmith M, Connolly JA, Kumar N, Wu J, Yarbrough LR, van der Kooy D. Conserved beta-tubulin binding domain for the microtubule-associated motors underlying sperm motility and fast axonal transport. Cell Motil Cytoskeleton. 1991; 20(3):249-62. PMID: 1723030.
      View in: PubMed
    77. Wu J, Yarbrough LR. Expression of the alpha and beta tubulin genes of the African trypanosome in Escherichia coli. Gene. 1987; 61(1):51-62. PMID: 3327752.
      View in: PubMed
    78. Hunzicker-Dunn M, LaBarbera AR. Unique properties of the follicle-stimulating hormone- and cholera toxin-sensitive adenylyl cyclase of immature granulosa cells. Endocrinology. 1986 Jan; 118(1):302-11. PMID: 3000740.
      View in: PubMed
    79. Kimmel BE, Samson S, Wu J, Hirschberg R, Yarbrough LR. Tubulin genes of the African trypanosome Trypanosoma brucei rhodesiense:nucleotide sequence of a 3.7-kb fragment containing genes for alpha and beta tubulins. Gene. 1985; 35(3):237-48. PMID: 4043732.
      View in: PubMed
    Wu's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _